Health officials in China are closely monitoring human metapneumovirus (HMPV) following a notable rise in cases, according to Reuters. Despite the uptick, experts emphasize that the situation is not alarming, and the likelihood of a pandemic similar to COVID-19 remains low.
The World Health Organization noted that respiratory illnesses in China this year are less severe compared to 2024. Meanwhile, the Centers for Disease Control and Prevention in the United States reported a slight increase in HMPV cases since November, with 1.94% of weekly tests returning positive as of late December. The CDC is staying vigilant and maintaining communication with international health partners but stated that the increase in cases is not a cause for concern in the U.S.
What Is HMPV?
HMPV, first identified in 2001, belongs to the pneumoviridae family, which also includes respiratory syncytial virus (RSV). It causes respiratory illnesses that can range from mild colds to more severe conditions like bronchitis or pneumonia.
Symptoms and Risk Groups
Symptoms of HMPV include cough, nasal congestion, fever, and shortness of breath. The virus primarily affects young children and older adults over 65, with an incubation period of three to six days. Like the flu, HMPV is seasonal, peaking in winter and spring.
Prevention and Treatment
Although there is no specific treatment or vaccine for HMPV, preventive measures can help reduce the spread:
- Wash hands thoroughly for at least 20 seconds.
- Avoid touching your face with unwashed hands.
- Stay away from sick individuals.
- Cover your mouth and nose when coughing or sneezing.
- Refrain from sharing utensils or engaging in close contact like kissing when symptomatic.
For those with severe symptoms, supportive care such as oxygen therapy may be necessary.
Health officials urge continued vigilance and adherence to hygiene practices to minimize the spread of HMPV.
Stay tuned for more updates on the HMPV on QueOndaMagazine.com
